Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Majhail, Navneet S  [Clear All Filters]
2019
Cohen, J.A., Baldassari, L.E., Atkins, H.L., Bowen, J.D., Bredeson, C., Carpenter, P.A., Corboy, J.R., Freedman, M.S., Griffith, L.M., Lowsky, R., et al. (2019). AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR TREATMENT-REFRACTORY RELAPSING MULTIPLE SCLEROSIS: POSITION STATEMENT FROM THE AMERICAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION.Biol Blood Marrow Transplant.
Singer, S., Dean, R., Zhao, Q., Sharma, N., Abounader, D., Elder, P., Hofmeister, C.C., Benson, D.M., Rosko, A., Penza, S., et al. (2019). BEAM Vs BUCYVP16 CONDITIONING PRIOR TO AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN PATIENTS WITH HODGKIN'S LYMPHOMA.Biol Blood Marrow Transplant.
Patel, S.S., Rybicki, L., Pohlman, B., Bolwell, B., Gerds, A.T., Hamilton, B.K., Hanna, R., Kalaycio, M., Majhail, N.S., and Sobecks, R. (2019). Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.Hematol Oncol Stem Cell Ther.
Patel, S.S., Rybicki, L.A., Yurch, M., Thomas, D., Liu, H., Dean, R., Jagadeesh, D., Hill, B., Pohlman, B., Bolwell, B., et al. (2019). Influence of major histocompatibility complex class I chain-related gene a polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation.Hematol Oncol Stem Cell Ther.
Modi, A.R., Majhail, N.S., Rybicki, L., Athans, V., Carlstrom, K., Srinivas, P., Lang, D.M., Sobecks, R., and Kovacs, C.S. (2019). Penicillin Allergy Skin Testing as an Antibiotic Stewardship Intervention Reduces Alternative Antibiotic Exposures in Hematopoietic Stem Cell Transplant Recipients.Transpl Infect Dise13175.
Modi, A., Rybicki, L., Majhail, N.S., and Mossad, S.Beniameen (2019). Severity of Acute Gastrointestinal Graft-Versus-Host Disease is Associated with Incidence of Bloodstream Infection after Adult Allogeneic Hematopoietic Stem Cell Transplantation.Transpl Infect Dise13217.
Hill, B.T., Rybicki, L.A., Urban, T.A., Lucena, M., Jagadeesh, D., Gerds, A.T., Dean, R.M., Sobecks, R.M., Pohlman, B., Bolwell, B., et al. (2019). Therapeutic Dose Monitoring of Busulfan is Associated with a Reduction in Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.Biol Blood Marrow Transplant.